8月21日中银创新医疗混合C净值增长2.23%，今年来累计上涨90.32%

Group 1 - The core viewpoint of the news is the performance and holdings of the Zhongyin Innovation Medical Mixed Fund C, which has shown significant growth in recent months and year-to-date [1] - As of August 21, 2025, the latest net value of the fund is 2.2560 yuan, reflecting a growth of 2.23% [1] - The fund's one-month return is 6.73%, six-month return is 69.34%, and year-to-date return is 90.32%, with respective rankings of 4351 out of 4701, 29 out of 4538, and 33 out of 4492 in its category [1] Group 2 - The top ten stock holdings of the Zhongyin Innovation Medical Mixed Fund C account for a total of 62.83%, with significant positions in companies such as Innovent Biologics (8.33%), Kelun-Biotech (8.15%), and Hengrui Medicine (8.08%) [1] - The fund was established on October 30, 2020, and as of June 30, 2025, it has a total scale of 2.686 billion yuan [1] - The fund manager, Zheng Ning, has a background in stock research and has held various positions in asset management companies before joining Zhongyin Fund Management in 2022 [2]